{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:16:54Z","timestamp":1783545414155,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Slovenian Research And Innovation Agency","doi-asserted-by":"crossref","award":["J7-4540, P3-0429, P5-0128, P5-0117, P5-0441."],"award-info":[{"award-number":["J7-4540, P3-0429, P5-0128, P5-0117, P5-0441."]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research And Innovation Agency","doi-asserted-by":"crossref","award":["J7-4540, P3-0429, P5-0128, P5-0117, P5-0441."],"award-info":[{"award-number":["J7-4540, P3-0429, P5-0128, P5-0117, P5-0441."]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research And Innovation Agency","doi-asserted-by":"crossref","award":["J7-4540, P3-0429, P5-0128, P5-0117, P5-0441."],"award-info":[{"award-number":["J7-4540, P3-0429, P5-0128, P5-0117, P5-0441."]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research And Innovation Agency","doi-asserted-by":"crossref","award":["J7-4540, P3-0429, P5-0128, P5-0117, P5-0441."],"award-info":[{"award-number":["J7-4540, P3-0429, P5-0128, P5-0117, P5-0441."]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research And Innovation Agency","doi-asserted-by":"crossref","award":["J7-4540, P3-0429, P5-0128, P5-0117, P5-0441."],"award-info":[{"award-number":["J7-4540, P3-0429, P5-0128, P5-0117, P5-0441."]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research And Innovation Agency","doi-asserted-by":"crossref","award":["J7-4540, P3-0429, P5-0128, P5-0117, P5-0441."],"award-info":[{"award-number":["J7-4540, P3-0429, P5-0128, P5-0117, P5-0441."]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research And Innovation Agency","doi-asserted-by":"crossref","award":["J7-4540, P3-0429, P5-0128, P5-0117, P5-0441."],"award-info":[{"award-number":["J7-4540, P3-0429, P5-0128, P5-0117, P5-0441."]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research And Innovation Agency","doi-asserted-by":"crossref","award":["J7-4540, P3-0429, P5-0128, P5-0117, P5-0441."],"award-info":[{"award-number":["J7-4540, P3-0429, P5-0128, P5-0117, P5-0441."]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The aim of this study was to assess the extent of financial toxicity in patients with cancer in Slovenia, measured as perceived financial strain and out-of-pocket expenditures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The prospective, cross-sectional study was done at Institute of Oncology Ljubljana from June to October 2023. A newly created individual questionnaire was utilized to obtain data on financial toxicity. Patients completed the questionnaire either on paper or online, with or without the assistance of a researcher. The statistical analysis was based on descriptive and inferential statistics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 901 surveys were disseminated, of which 659 were returned, corresponding to a response rate of 73%. Most patients had compulsory health insurance and were diagnosed in the public healthcare system. Following a cancer diagnosis, 178 (27%) patients reported a decline in financial satisfaction (subjective assessment), while 150 (22.7%) patients observed a change in their financial capability (objective assessment). Younger patients (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), female patients (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.004), patients with lower net household income (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and patients who were employed before the diagnosis (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) were at a greater risk for financial toxicity. Patients with breast cancer and colorectal, endometrial, skin (including melanoma), esophageal, stomach, kidney, bladder cancers, and lymphoma had higher self-reported subjective and objective financial toxicity than patients with prostate, lung, and head and neck cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This article represents the first comprehensive assessment of financial toxicity among patients with cancer in Slovenia, using perceived financial strain and out-of-pocket expenditures. Most patients reported no significant out-of-pocket costs for the treatment they received. About a quarter of patients with cancer experience financial difficulties.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00520-025-09591-7","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T12:11:43Z","timestamp":1748607103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of financial toxicity in patients with cancer in Slovenia"],"prefix":"10.1007","volume":"33","author":[{"given":"Katja","family":"V\u00f6r\u00f6\u0161","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjeta","family":"Skubic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1924-7516","authenticated-orcid":false,"given":"Mojca","family":"Bavda\u017e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0356-1204","authenticated-orcid":false,"given":"Petra","family":"Do\u0161enovi\u0107 Bon\u010da","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0559-3813","authenticated-orcid":false,"given":"Andra\u017e","family":"Perhavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3100-7208","authenticated-orcid":false,"given":"Tja\u0161a","family":"Redek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9585-1785","authenticated-orcid":false,"given":"Helena Barbara","family":"Zobec Logar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5551-6616","authenticated-orcid":false,"given":"Ivica","family":"Rato\u0161a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"issue":"11","key":"9591_CR1","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1093\/tbm\/ibab091","volume":"11","author":"HR Abrams","year":"2021","unstructured":"Abrams HR, Durbin S, Huang CX et al (2021) Financial toxicity in cancer care: origins, impact, and solutions. Transl Behav Med 11(11):2043\u20132054","journal-title":"Transl Behav Med"},{"issue":"2","key":"9591_CR2","first-page":"80-1","volume":"27","author":"SY Zafar","year":"2013","unstructured":"Zafar SY, Abernethy AP (2013) Financial toxicity, Part I: a new name for a growing problem. Oncology (Williston Park) 27(2):80-1\u2013149","journal-title":"Oncology (Williston Park)"},{"issue":"9","key":"9591_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.21037\/atm.2018.03.28","volume":"6","author":"G Tran","year":"2018","unstructured":"Tran G, Zafar SY (2018) Financial toxicity and implications for cancer care in the era of molecular and immune therapies. Ann Transl Med 6(9):166","journal-title":"Ann Transl Med"},{"key":"9591_CR4","unstructured":"CANCER TODAY: Estimated number of new cases in 2020, World, both Sexex, all Ages (excl. NMSC) [internet]. Lyon: Cancer Today. Available at: https:\/\/gco.iarc.fr\/today."},{"key":"9591_CR5","unstructured":"Rak v Sloveniji 2020. Ljubljana: Onkolo\u0161ki in\u0161titut Ljubljana, Epidemiologija in register raka. Register raka Republike Slovenije 2023."},{"key":"9591_CR6","unstructured":"Snyder A. R, Chang J. G. Defines financial toxicity, identifies patients most at risk, and outlines ongoing clinical trials investigating this issue [Internet]. 2019. Available from: https:\/\/www.facs.org\/for-medical-professionals\/news-publications\/news-and-articles\/bulletin\/2019\/09\/financial-toxicity-a-growing-burden-for-canc."},{"issue":"3","key":"9591_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0176-2680(99)00063-4","volume":"16","author":"M Jofre-Bonet","year":"2000","unstructured":"Jofre-Bonet M (2000) Health care: private and\/or public provision. Eur J Polit Econ 16(3):469\u2013489","journal-title":"Eur J Polit Econ"},{"key":"9591_CR8","unstructured":"Compulsory Health Insurance [Internet]. [cited 2025 Feb 5]. Available from: https:\/\/www.zzzs.si\/en\/compulsory-health-insurance\/classes-of-rights-under-compulsory-health-insurance\/"},{"issue":"2","key":"9591_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11764-020-00862-2","volume":"14","author":"AG de Boer","year":"2020","unstructured":"de Boer AG, Torp S, Popa A et al (2020) Long-term work retention after treatment for cancer: a systematic review and meta-analysis. J Cancer Surviv 14(2):135\u2013150","journal-title":"J Cancer Surviv"},{"issue":"2","key":"9591_CR10","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3390\/curroncol28020117","volume":"28","author":"N Iragorri","year":"2021","unstructured":"Iragorri N, de Oliveira C, Fitzgerald N et al (2021) The out-of-pocket cost burden of cancer care\u2014a systematic literature review. Curr Oncol 28(2):1216\u20131248","journal-title":"Curr Oncol"},{"issue":"5","key":"9591_CR11","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.3390\/curroncol30050371","volume":"30","author":"J Smith","year":"2023","unstructured":"Smith J, Yu J, Gordon LG et al (2023) Financial toxicity and out-of-pocket costs for patients with head and neck cancer. Curr Oncol 30(5):4922\u20134935","journal-title":"Curr Oncol"},{"issue":"1","key":"9591_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11764-018-0723-7","volume":"13","author":"A Pearce","year":"2019","unstructured":"Pearce A, Tomalin B, Kaambwa B et al (2019) Financial toxicity is more than costs of care: the relationship between employment and financial toxicity in long-term cancer survivors. J Cancer Surviv 13(1):10\u201320","journal-title":"J Cancer Surviv"},{"issue":"5","key":"9591_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3322\/caac.21730","volume":"72","author":"GL Smith","year":"2022","unstructured":"Smith GL, Banegas MP, Acquati C et al (2022) Navigating financial toxicity in patients with cancer: a multidisciplinary management approach. CA Cancer J Clin 72(5):437\u2013453","journal-title":"CA Cancer J Clin"},{"key":"9591_CR14","doi-asserted-by":"crossref","unstructured":"Al-Aqeel S, Alnaim L, Alghaith J, et al. Cancer impacts on out-of-pocket expenses, income loss, and informal (unpaid) care: a cross-sectional study of patient perspective. J Patient Exp 2021; 8.","DOI":"10.1177\/23743735211049651"},{"issue":"2","key":"9591_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11764-020-00862-2","volume":"14","author":"AG de Boer","year":"2020","unstructured":"de Boer AG, Torp S, Popa A et al (2020) Long-term work retention after treatment for cancer: a systematic review and meta-analysis. J Cancer Surviv 14(2):135\u2013150","journal-title":"J Cancer Surviv"},{"issue":"3","key":"9591_CR16","doi-asserted-by":"publisher","first-page":"e416","DOI":"10.1016\/S2214-109X(21)00595-7","volume":"10","author":"YC Kong","year":"2022","unstructured":"Kong YC, Kimman M, Subramaniam SD et al (2022) Out-of-pocket payments for complementary medicine following cancer and the effect on financial outcomes in middle-income countries in southeast Asia: a prospective cohort study. Lancet Glob Health 10(3):e416\u2013e428","journal-title":"Lancet Glob Health"},{"key":"9591_CR17","unstructured":"Facit.org [Internet]. COST: a FACIT measure of financial toxicity."},{"issue":"19","key":"9591_CR18","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.3390\/cancers13195015","volume":"13","author":"S Pauge","year":"2021","unstructured":"Pauge S, Surmann B, Mehlis K et al (2021) Patient-reported financial distress in cancer: a systematic review of risk factors in universal healthcare systems. Cancers (Basel) 13(19):5015","journal-title":"Cancers (Basel)"},{"issue":"10","key":"9591_CR19","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1007\/s00520-020-05620-9","volume":"28","author":"CJ Longo","year":"2020","unstructured":"Longo CJ, Fitch MI, Banfield L et al (2020) Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review. Support Care Cancer 28(10):4645\u20134665","journal-title":"Support Care Cancer"},{"key":"9591_CR20","unstructured":"Zakon o zdravstvenem varstvu in zdravstvenem zavarovanju. Uradni list RS, \u0161t. 72\/06. Available at: https:\/\/pisrs.si\/pregledPredpisa?id=ZAKO213."},{"issue":"10","key":"9591_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-049128","volume":"11","author":"S Riva","year":"2021","unstructured":"Riva S, Arenare L, Di Maio M, Efficace F, Montesarchio V, Frontini L et al (2021) Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system. BMJ Open 11(10):e049128","journal-title":"BMJ Open"},{"issue":"17","key":"9591_CR22","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1002\/cncr.33032","volume":"126","author":"K Hueniken","year":"2020","unstructured":"Hueniken K, Douglas CM, Jethwa AR, Mirshams M, Eng L, Hope A et al (2020) Measuring financial toxicity incurred after treatment of head and neck cancer: development and validation of the Financial Index of Toxicity questionnaire. Cancer 126(17):4042\u20134050","journal-title":"Cancer"},{"key":"9591_CR23","unstructured":"1KA (Version 23.06.20) [software]. (2023). Ljubljana: Faculty of Social Sciences. Available via https:\/\/www.1ka.si."},{"key":"9591_CR24","unstructured":"Republika Slovenija eUPRAVA: Upokojitev starostna pokojnina [internet]. Ljubljana: Zavod za pokojninsko in invalidsko zavarovanje Slovenije [cited 2023 Oct 17]. Available from: https:\/\/e-uprava.gov.si\/si\/podrocja\/delo-upokojitev\/upokojitev\/starostna-pokojnina.html."},{"issue":"3","key":"9591_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1200\/JCO.2015.62.0468","volume":"34","author":"KR Yabroff","year":"2016","unstructured":"Yabroff KR, Dowling EC, Guy GP et al (2016) Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol 34(3):259\u2013267","journal-title":"J Clin Oncol"},{"issue":"7","key":"9591_CR26","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/annonc\/mdz140","volume":"30","author":"J Witte","year":"2019","unstructured":"Witte J, Mehlis K, Surmann B et al (2019) Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications. Ann Oncol 30(7):1061\u20131070","journal-title":"Ann Oncol"},{"key":"9591_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JGO.19.11000","volume":"5","author":"K Honda","year":"2019","unstructured":"Honda K, Gyawali B, Ando M et al (2019) Prospective survey of financial toxicity measured by the comprehensive score for financial toxicity in Japanese patients with cancer. J Glob Oncol 5:1\u20138","journal-title":"J Glob Oncol"},{"issue":"1","key":"9591_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00520-021-06406-3","volume":"30","author":"M B\u00fcttner","year":"2022","unstructured":"B\u00fcttner M, Singer S, Hentschel L et al (2022) Financial toxicity in sarcoma patients and survivors in Germany: results from the multicenter PROSa study. Support Care Cancer 30(1):187\u2013196","journal-title":"Support Care Cancer"},{"issue":"12","key":"9591_CR29","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/annonc\/mdw433","volume":"27","author":"F Perrone","year":"2016","unstructured":"Perrone F, Jommi C, Di Maio M et al (2016) The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy. Ann Oncol 27(12):2224\u20132229","journal-title":"Ann Oncol"},{"issue":"8","key":"9591_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/cncr.29808","volume":"122","author":"HP Kale","year":"2016","unstructured":"Kale HP, Carroll NV (2016) Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors. Cancer 122(8):283\u2013289","journal-title":"Cancer"},{"key":"9591_CR31","unstructured":"European Parliament: Gender pay gap in Europe: facts and figures (infographic) [internet]. Bruselj: European Parliament . Available from: https:\/\/www.europarl.europa.eu\/news\/en\/headlines\/society\/20200227STO73519\/gender-pay-gap-in-europe-facts-and-figures-infographic."},{"issue":"1","key":"9591_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00520-021-06406-3","volume":"30","author":"M B\u00fcttner","year":"2022","unstructured":"B\u00fcttner M, Singer S, Hentschel L et al (2022) Financial toxicity in sarcoma patients and survivors in Germany: results from the multicenter PROSa study. Support Care Cancer 30(1):187\u2013196","journal-title":"Support Care Cancer"},{"issue":"12","key":"9591_CR33","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.1007\/s00520-020-05719-z","volume":"28","author":"F Mols","year":"2020","unstructured":"Mols F, Tomalin B, Pearce A et al (2020) Financial toxicity and employment status in cancer survivors.\u00a0 A systematic literature review. Supportive Care in Cancer 28(12):5693\u2013708","journal-title":"Supportive Care in Cancer"},{"issue":"4","key":"9591_CR34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1634\/theoncologist.2012-0279","volume":"18","author":"SY Zafar","year":"2013","unstructured":"Zafar SY, Peppercorn JM, Schrag D et al (2013) The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient\u2019s experience. Oncologist 18(4):381\u2013390","journal-title":"Oncologist"},{"issue":"12","key":"9591_CR35","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00066-022-01936-z","volume":"198","author":"A Fabian","year":"2022","unstructured":"Fabian A, Domschikowski J, Greiner W et al (2022) Financial toxicity in cancer patients treated with radiotherapy in Germany\u2014a cross-sectional study. Strahlenther Onkol 198(12):1053\u20131061","journal-title":"Strahlenther Onkol"},{"issue":"6","key":"9591_CR36","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/ijgc-2021-002475","volume":"31","author":"KM Esselen","year":"2021","unstructured":"Esselen KM, Gompers A, Hacker MR et al (2021) Evaluating meaningful levels of financial toxicity in gynecologic cancers. International Journal of Gynecologic Cancer 31(6):801\u2013806","journal-title":"International Journal of Gynecologic Cancer"},{"key":"9591_CR37","unstructured":"Republika Slovenija Euprava: Pravice brezposelnih oseb [internet]. Ljubljana: Ministrstvo za delo, dru\u017eino, socialne zadeve in enake mo\u017enosti [cited 2023 Nov 13]. Available from: https:\/\/e-uprava.gov.si\/si\/podrocja\/delo-upokojitev\/brezposelnost-iskanje-dela\/pravice-brezposelne-osebe.html."},{"issue":"2","key":"9591_CR38","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00520-015-2832-4","volume":"24","author":"L Sharp","year":"2016","unstructured":"Sharp L, Timmons A (2016) Pre-diagnosis employment status and financial circumstances predict cancer-related financial stress and strain among breast and prostate cancer survivors. Support Care Cancer 24(2):699\u2013709","journal-title":"Support Care Cancer"},{"issue":"12","key":"9591_CR39","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/annonc\/mdw433","volume":"27","author":"F Perrone","year":"2016","unstructured":"Perrone F, Jommi C, Di Maio M et al (2016) The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy. Ann Oncol 27(12):2224\u20132229","journal-title":"Ann Oncol"},{"issue":"1","key":"9591_CR40","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12885-020-07028-4","volume":"20","author":"K Mehlis","year":"2020","unstructured":"Mehlis K, Witte J, Surmann B et al (2020) The patient-level effect of the cost of cancer care \u2013 financial burden in German Cancer patients. BMC Cancer 20(1):529","journal-title":"BMC Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09591-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09591-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09591-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T18:02:59Z","timestamp":1749492179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09591-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["9591"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09591-7","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"24 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board and Ethical Committee (approval number ERIDNPVO-0031\/2023) and by the National Medical Ethics Committee (approval number 0120\u2013105\/2023\/3). The study complied with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients signed an informed consent to participate in the study and to allow processing of their personal data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have nothing to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}],"article-number":"515"}}